Personal profile
Education
- 2002 Ph.D. National Taiwan University
- 1994 M.S. Taipei Medical University
Experience
- 2023- Dean, College of Medical Science and Technology, Taipei Medical University
- 2020-2023 Vice Dean, College of Medical Science and Technology, Taipei Medical University
- 2019-2022 Director, Ph.D. Program in Drug Discovery and Development Industry, Taipei Medical University
- 2018- Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University
- 2017- Professor, Ph.D. Program in Biotechnology Research and Development, , Taipei Medical University
- 2016-2018 Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013-2016 Associate Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2008-2013 Assistant Professor, Department of Pharmacology, Taipei Medical University
- 2009-2013 Assistant Investigator, National Health Research Institutes
- 2007-2009 Assistant Investigator, National Taiwan University
- 2002-2007 Postdoctor, National Taiwan Universiy
- 1994-1998 Teaching Assistant, Chang-Gung University
Awards
- 2019 Single Research Project Budget Award, Taipei Medical University
Research Interests
- Drug Discovery
- Disease animal model
- Pharmacology
Related Link
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
115年度智慧健康產業跨領域生技人才培育計畫（申請領域：精準醫療）
Pan, S.-L. (PI)
2/1/26 → 1/31/27
Project: A - Government Institution › d - Ministry of Education
-
CDK8 抑制劑之藥效評估與作用機轉研究
Pan, S.-L. (PI)
1/1/26 → 12/31/26
Project: B - Project of TMU › i - Other (Funded by TMU)
-
設計與開發新穎 DDR1 抑制劑應用於神經膠質母細胞瘤治療
Pan, S.-L. (PI)
1/1/26 → 12/31/26
Project: A - Government Institution › a - National Health Research Institutes
-
以人工智慧技術驅動糖尿病治療藥物之研發與機轉探討(1/2)
Pan, S.-L. (PI)
10/1/25 → 9/30/26
Project: A - Government Institution › b - National Science and Technology Council
-
Ai-Driven Development and Preclinical Evaluation of Novel Drug Candidates for Brain Cancer Therapy
Pan, S.-L. (PI)
9/1/25 → 5/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Consensus Pharmacological Interactions for PLK2 Inhibitor Identification in Colorectal Cancer Treatment
Wu, Y. W., Yang, C. L., Lin, T. E., Yeh, Y. H., Fang-Chin, Y. T., Sung, T. Y., Yen, S. C., Hsieh, J. H., Chung, C. C., Pan, S. L. & Hsu, K. C., Jan 12 2026, In: Journal of Chemical Information and Modeling. 66, 1, p. 577-590 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Identification and biological evaluation of benzimidazole-based compounds as novel TGFβR1 inhibitors
Tseng, H. J., Wu, Y. W., Chen, Y. L., Lin, T. E., Fang-Chin, Y. T., Wu, Y. L., Sung, T. Y., Yen, S. C., Hsieh, J. H., Hsu, K. C. & Pan, S. L., 2026, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 41, 1, 2600746.Research output: Contribution to journal › Article › peer-review
Open Access -
Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer
Chung, C. H., Hsu, K. C., Huang, M. M., Tu, H. J., Pan, S. L. & Chao, M. W., Dec 31 2025, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 40, 1, 2538673.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Exploring diarylheptanoid derivatives to target LIMK1 as potential agents against colorectal cancer
Chen, L. C., Chang, T. C., Tseng, H. J., Chu, J. C., Huang, Y. Y., Peng, H. Y., Kuo, Y. C., Wu, Y. W., Lin, T. E., Yen, S. C., Hsu, K. C., Huang, W. J. & Pan, S. L., Dec 2025, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 40, 1, p. 2583826 2583826.Research output: Contribution to journal › Article › peer-review
Open Access -
Identification and Biological Evaluation of a Novel CLK4 Inhibitor Targeting Alternative Splicing in Pancreatic Cancer Using Structure-Based Virtual Screening
Yang, C. L., Wu, Y. W., Tu, H. J., Yeh, Y. H., Lin, T. E., Sung, T. Y., Li, M. C., Yen, S. C., Hsieh, J. H., Yu, M. C., Hsieh, S. Y., Hsieh, H. P., Pan, S. L. & Hsu, K. C., May 1 2025, In: Advanced Science. 12, 19, p. e2416323 1 p., 2416323.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Citations (Scopus)
Datasets
-
Additional file 1: of The anticancer effects of MPT0G211, a novel HDAC6 inhibitor, combined with chemotherapeutic agents in human acute leukemia cells
Tu, H.-J. (Contributor), Lin, Y.-J. (Contributor), Chao, M.-W. (Contributor), Sung, T.-Y. (Contributor), Wu, Y.-W. (Contributor), Chen, Y.-Y. (Contributor), Lin, M.-H. (Contributor), Liou, J.-P. (Contributor), Pan, S.-L. (Contributor) & Yang, C.-R. (Contributor), Unknown Publisher, Dec 29 2018
DOI: 10.6084/m9.figshare.7531874.v1, https://springernature.figshare.com/articles/Additional_file_1_of_The_anticancer_effects_of_MPT0G211_a_novel_HDAC6_inhibitor_combined_with_chemotherapeutic_agents_in_human_acute_leukemia_cells/7531874/1
Dataset
-
Additional file 5: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chang, L.-H. (Contributor), Liou, J.-P. (Creator), Lai, M.-J. (Contributor), Chang, C.-D. (Contributor), Tu, H.-J. (Contributor), Chao, M.-W. (Contributor), Pan, S.-L. (Contributor), Chen, Y.-Y. (Creator) & Teng, C.-M. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202902.v1, https://doi.org/10.6084%2Fm9.figshare.8202902.v1
Dataset
-
Additional file 3: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202890.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202890/1
Dataset
-
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.c.4522856.v1, https://springernature.figshare.com/collections/Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/4522856/1
Dataset
-
Additional file 2: of Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status
Chao, M.-W. (Contributor), Chang, L.-H. (Contributor), Tu, H.-J. (Contributor), Chang, C.-D. (Contributor), Lai, M.-J. (Contributor), Chen, Y.-Y. (Creator), Liou, J.-P. (Creator), Teng, C.-M. (Contributor) & Pan, S.-L. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.8202887.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Combination_treatment_strategy_for_pancreatic_cancer_involving_the_novel_HDAC_inhibitor_MPT0E028_with_a_MEK_inhibitor_beyond_K-Ras_status/8202887/1
Dataset